Helen Y Chen

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., G.d. Searle & Company, Serenete Corporation. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Y Chen. Retrieved from https://idiyas.com/inventor/helen-y-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 3)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 159(Granted Patents)

Location History:

Livingston, NJ (US) (1998 - 2004)
Lawrenceville, GA (US) (2018 - 2020)
Marlboro, NJ (US) (2013 - 2022)
Florham Park, NJ (US) (2024)

Company Filing History:

10 out of 2,405

Merck Sharp + Dohme Corp.

patents

8 out of 1,323

G.d. Searle & Company

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Antidiabetic Compounds

Bicyclic Compounds

Beta-Lactamase Inhibitors

Sodium Channel Inhibitors

Monobactam Compounds

Food Preparation Device

Isoquinoline Derivatives

Estrogen Receptor Modulators

Cinnamic Acid Derivatives

Carbapenem Compounds

Phenylene Derivatives

Hydrolase Inhibitors

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

2. 11932637 - Chromane amidine monobactam compounds for the treatment of bacterial infections (2024-03-19),

3. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections (2022-01-25),

4. 10968193 - Antidiabetic bicyclic compounds (2021-04-06),

5. 10765257 - Modularized food preparation device and tray structure for use thereof (2020-09-08),

6. 10736464 - System and method for operating a food preparation device (2020-08-11),

7. 10100042 - [5,6]—fused bicyclic antidiabetic compounds (2018-10-16),

8. 10065945 - Isoquinoline derivatives as MGAT2 inhibitors (2018-09-04),

9. 9918590 - Food preparation device (2018-03-20),

10. 9840512 - Antidiabetic bicyclic compounds (2017-12-12),

11. 9340530 - Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists (2016-05-17),

12. 9139585 - Inhibitors of the Renal Outer Medullary Potassium channel (2015-09-22),

13. 8487093 - β-lactamase inhibitors (2013-07-16),

14. 8440643 - Inhibitors of beta-lactamase (2013-05-14),

15. 6750213 - Estrogen receptor modulators (2004-06-15),

Title: The Innovations of Inventor Helen Y Chen

Introduction:

Inventor Helen Y Chen from Marlboro, NJ, is a prolific innovator with a total of 20 patents to her name.

Latest Patents:

Chromane amidine monobactam compounds for the treatment of bacterial infections - Helen Y Chen's patented monobactam compounds are designed to combat bacterial infections effectively. The compositions containing these compounds show promise in the field of pharmaceuticals.

Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections - Her biaryl monobactam compounds also offer potential solutions for treating bacterial infections. These compounds, along with additional beta-lactam antibiotics, present new avenues for fighting against bacteria.

Career Highlights:

Helen Y Chen has contributed her expertise to renowned companies such as Merck Sharp & Dohme Corporation and G.d. Searle & Company. Her innovative work has made a significant impact in the field of pharmaceuticals.

Collaborations:

During her career, Helen Y Chen has collaborated with notable individuals in the industry, including Barbara B Chen and Mark Andrew Russell. These collaborations have led to the development of groundbreaking solutions for treating bacterial infections.

Conclusion:

In conclusion, Helen Y Chen's dedication to innovation in pharmaceuticals has resulted in numerous patents that have the potential to revolutionize the treatment of bacterial infections. Her collaborations and career highlights further showcase her expertise and contributions to the field.

Profile summary based on public USPTO records.